International Journal of Medical and Dental Sciences

Open Access Open Access  Restricted Access Subscription Access

Effectiveness of Oral and Intravenous PPI for Peptic Ulcer Re-Bleeding and Management after Endoscopic Therapy


Affiliations
1 Department of General surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
2 Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China
3 Zhongnan Hospital of Wuhan University, Wuhan, China
 

To explain the effectiveness of different oral and intravenous (IV) Proton Pump Inhibitors (PPI) used in the management of peptic ulcer re-bleeding after successful endoscopic intervention. This article offers the summarization of various articles on PPI which are published in a well-known journals. All the articles used the same method in the management of peptic ulcer re-bleeding. Rockall risk scoring system were used for grading the rate of the bleeding. Pubmed and Embase was used to identify the related articles that assessed the efficacy of PPI and found Six articles matched our criteria. All the results where P<0.05 where considered significant for writing this review article. Neither any alterations or modifications nor any softwares were used in this article. All the results and conclusions were briefed and summarized carefully after a through discussion of the articles included in our review.

Keywords

Proton Pump Inhibitors (PPI), Endoscopic Therapy, Rebleeding, Peptic Ulcer, Hemostasis, Mortality Rate, Surgical Rate.
User
Notifications
Font Size


  • Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, et al. Effect of Intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000;B:310-6.

  • Freston JW. Overview of medical therapy of peptic ulcer disease. Gastroenterol Clin North Am 1990;19:121-40.

  • Yavorski RT, Wong RK, Maydonovitch C, Battin LS, Furnia A, Amundson DE. Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol 1995;90:568-73.

  • Green FW Jr, Kaplan MM, Curtis LE, Levine PH. Effects of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor to prolonged gastro duodenal mucosal haemorrhage. Gastroenterology 1978;74:38-43.

  • Johnston JH. Endoscopic risk factors for bleeding peptic ulcer. Gastrointest Endosc 1990;36:S16- S20.

  • Green FW Jr, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978;74:38-43.

  • Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a metaanalysis. Gastroenterology 1992;102:139-48.

  • Consensus statement on therapeutic endoscopy and bleeding ulcers. Consensus Development Panel. Gastrointest Endosc 1990;36:S62-5.

  • Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 1998;158:54-8.

  • Javid G, Zargar SA, U Saif R, Khan BA, Yatoo GN, Shah AH, et al. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer. J Gastroenterol Hepatol 2009;24:1236-43.

  • Tsai JJ, Hsu YC, Perng CL, Lin HJ. Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection. Br J Clin Pharmacol 2009;67:32632.

  • Cheng HC, Chang WL, Yeh YC, Chen WY, Tsai YC, Sheu BS. Seven-day intravenous lowdose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities. Gastrointest Endosc 2009;70:433-9.

  • Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000;343:310-6.

  • Netzer P, Gaia C, Sandoz M, Huluk T, Gut A, Halter F, et al. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol 1999;94:351-7.

  • Andersen J, Strom M, Naesdal J, Leire K, Walan A. Intravenous omeprazole: effect of a loading dose on 24-h intragastric pH. Aliment Pharmacol Ther 1990;4:65-72.

  • Hung WK, Li VK, Chung CK, Ying MW, Loo CK, Liu CK, et al. Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric pH and recurrent bleeding in peptic ulcers. ANZ J Surg 2007;77:677-81.

  • Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, et al. International Consensus Upper Gastrointestinal Bleeding Conference Group: International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010;152:101-13.

  • Sung JJ, Chan FK, Chen M, Ching JY, Ho KY, Kachintorn U, et al. Asia-Pacific Working Group. Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding. Gut 2011; 60:1170-7.

  • Laterre PF, Horsmans Y. Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8 mg/hour on intragastric pH. Crit Care Med 2001;29:1931-5.

  • Kiilerich S, Rannem T, Elsborg L. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour Intragastric pH in patients with a history of duodenal ulcer. Digestion 1995;56:25-30.

  • Udd M, Miettinen P, Palmu A, Heikkinen M, Janatuinen E, Pasanen P, et al. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized doubleblind study. Scand J Gastroenterol 2001;36:1332-8.

  • Sheu BS, Chi CH, Yang HB, Jen CM, Lin XZ. A three-day course of intravenous omeprazole plus antibiotics for H. pyloripositive bleeding duodenal ulcer. Hepatogastroenterology 1999;46:2363-71.

  • Cheng HC, Chuang SA, Kao YH, Kao AW, Chuang CH, Sheu BS. Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion. Hepatogastro enterology 2003;50:2270-3.

  • M Bardou, Y Toubouti, D Benhaberou-brun, E Rahme, AN Barkun, Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther 2005;21:677-86.

  • Hasselgren G, Lind T, Lundel L, Aadland E, Efskind P, Falk A, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol 1997;32:328–33.

  • Sung JJ, Chan FK, Lau JY, Yung MY, Leung WK, Wu JC, et al. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med 2003;139:237–43.

  • Gisbert JP, Gonzalez L, Calvet X, Roque M, Gabriel R, Pajares JM. Proton pump inhibitors versus H2-antagonists: a metaanalysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther 2001;15:917–26.

  • Barkun A, Bardou M, Marshall JK. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003;139:843–57.

  • Hsu-Heng Yen, Chia-Wei Yang, Wei-Wen Su, Maw-Soan Soon, Shun-Sheng Wu, HwaiJeng Lin. BMC Gastroeneterology 2012;12:66.


Abstract Views: 178

PDF Views: 126




  • Effectiveness of Oral and Intravenous PPI for Peptic Ulcer Re-Bleeding and Management after Endoscopic Therapy

Abstract Views: 178  |  PDF Views: 126

Authors

M. N. Rahmathullah
Department of General surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
P. S. Tikka
Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China
F. Husna
Department of General surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
Shahnawaz
Department of General surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
H. L. Wang
Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China
Y. F. Yuan
Department of General surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
H. Mohamed
Zhongnan Hospital of Wuhan University, Wuhan, China

Abstract


To explain the effectiveness of different oral and intravenous (IV) Proton Pump Inhibitors (PPI) used in the management of peptic ulcer re-bleeding after successful endoscopic intervention. This article offers the summarization of various articles on PPI which are published in a well-known journals. All the articles used the same method in the management of peptic ulcer re-bleeding. Rockall risk scoring system were used for grading the rate of the bleeding. Pubmed and Embase was used to identify the related articles that assessed the efficacy of PPI and found Six articles matched our criteria. All the results where P<0.05 where considered significant for writing this review article. Neither any alterations or modifications nor any softwares were used in this article. All the results and conclusions were briefed and summarized carefully after a through discussion of the articles included in our review.

Keywords


Proton Pump Inhibitors (PPI), Endoscopic Therapy, Rebleeding, Peptic Ulcer, Hemostasis, Mortality Rate, Surgical Rate.

References





DOI: https://doi.org/10.18311/ijmds%2F2016%2F100630